Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia
Laboratory surrogates for anti-atherosclerotic drug development
Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety
Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
Cerivastatin in primary hyperlipidemia—a multicenter analysis of efficacy and safety
Baltimore single 'No Panic' press release
Swiss Miss Ad Plan Booklet